| 000 | 01366 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513184332.0 | ||
| 264 | 0 | _c19990901 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1038/sj.bjp.0702476 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEzeamuzie, C I | |
| 245 | 0 | 0 |
_aAdenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cMay 1999 |
||
| 300 |
_a188-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCell Degranulation _xdrug effects |
| 650 | 0 | 4 |
_aComplement C5a _xmetabolism |
| 650 | 0 | 4 |
_aCytochalasin B _xpharmacology |
| 650 | 0 | 4 | _aEosinophil Peroxidase |
| 650 | 0 | 4 |
_aEosinophils _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aPeroxidases _xmetabolism |
| 650 | 0 | 4 | _aPurinergic P1 Receptor Agonists |
| 650 | 0 | 4 | _aPurinergic P1 Receptor Antagonists |
| 650 | 0 | 4 | _aReceptor, Adenosine A3 |
| 650 | 0 | 4 |
_aReceptors, Purinergic P1 _xphysiology |
| 650 | 0 | 4 |
_aSuperoxides _xmetabolism |
| 700 | 1 | _aPhilips, E | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 127 _gno. 1 _gp. 188-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0702476 _zAvailable from publisher's website |
| 999 |
_c10327974 _d10327974 |
||